Prestige Consumer Healthcare Inc (PBV) Stock Price & News

Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia. Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano. The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015. Wikipedia

About Prestige Consumer Healthcare Inc

CEOMatthew M. Mannelly

Employees890

Founded1996

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websiteprestigebrands.com

All values in USD	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	274,11 m	283,44 m	281,62 m	265,71 m
Cost of goods sold	120,04 m	123,63 m	132,40 m	123,63 m
Cost of revenue	120,04 m	123,63 m	132,40 m	123,63 m
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	66,74 m	69,73 m	65,37 m	77,97 m
Operating expense	74,40 m	77,32 m	73,72 m	86,72 m
Total operating expenses	194,44 m	200,95 m	206,12 m	210,35 m
Operating income	79,67 m	82,49 m	75,49 m	55,36 m
Other non operating income	-501,00 k	-10,00 m	708,00 k	-34,00 k
EBT including unusual items	69,13 m	61,81 m	64,77 m	38,54 m
EBT excluding unusual items	69,13 m	61,81 m	64,77 m	41,38 m
Income tax expense	26,92 m	15,12 m	10,84 m	9,36 m
Effective tax rate	38,94%	24,46%	16,74%	24,30%
Other operating expenses	-	-	-	-
Net income	42,21 m	46,70 m	53,93 m	29,18 m
Net profit margin	15,40%	16,47%	19,15%	10,98%
Earnings per share	0,86	1,14	1,23	0,98
Interest and investment income	-	-	-	-
Interest expense	-10,04 m	-10,67 m	-11,43 m	-13,94 m
Net interest expenses	-10,04 m	-10,67 m	-11,43 m	-13,94 m
Depreciation and amortization charges	7,66 m	7,59 m	8,35 m	8,75 m
EBITDA	87,33 m	90,08 m	83,84 m	64,11 m
Gain or loss from assets sale	131,00 k	9,00 k	25,00 k	191,00 k

Ask anything